Quick Comparison

Gotu KolaSulbutiamine
Half-Life2-4 hours (asiaticoside, madecassoside)5 hours
Typical DosageStandard: 500-1000 mg standardized extract daily (triterpenes: asiaticoside, madecassoside). Traditional dose: 1-2 grams dried herb as tea. ECa 233 is a well-studied standardized extract. Can be taken morning or evening — mild enough for bedtime use.Standard: 200-600 mg daily in 1-2 doses. Take with food (fat-soluble). Tolerance can develop with daily use — best cycled or used intermittently.
AdministrationOral (capsules, extract, tea, tincture). ECa 233 standardized extract for consistent dosing.Oral (capsules, tablets). Fat-soluble — take with food.
Research Papers9 papers10 papers
Categories

Mechanism of Action

Gotu Kola

Triterpene saponins (asiaticoside, madecassoside, asiatic acid, madecassic acid) are the primary bioactives. They increase BDNF expression in the hippocampus via CREB and ERK/MAPK pathways, promoting neuroplasticity, synaptogenesis, and memory formation. They enhance collagen type I synthesis through stimulation of fibroblasts and improve microcirculation via VEGF and angiopoietin modulation. Anxiolytic effects occur through positive allosteric modulation of GABA-A receptors (possibly at the benzodiazepine or neurosteroid site) and reduction of acoustic startle response (amygdala modulation). Gotu kola inhibits acetylcholinesterase (AChE), mildly increasing synaptic acetylcholine. Anti-inflammatory effects come from NF-kB inhibition (IkB stabilization) and TNF-alpha suppression. Asiatic acid may also activate PPAR-gamma.

Sulbutiamine

Sulbutiamine consists of two thiamine (vitamin B1) molecules connected by a disulfide bridge, conferring lipophilicity and efficient blood-brain barrier penetration via passive diffusion. In the brain, it is hydrolyzed to thiamine and increases thiamine diphosphate (TDP) levels—the cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, enzymes critical for glucose metabolism and the Krebs cycle. Sulbutiamine upregulates D1 dopamine receptors in the prefrontal cortex, possibly through reduced receptor internalization or increased expression. It modulates glutamatergic transmission (affecting NMDA/AMPA receptor function) and enhances cholinergic transmission. The anti-fatigue and memory-enhancing effects likely stem from improved neuronal glucose oxidation, increased ATP production, and enhanced dopaminergic and cholinergic tone in cognitive circuits.

Risks & Safety

Gotu Kola

Common

Very well-tolerated. Mild GI upset, drowsiness.

Serious

Rare hepatotoxicity reported — avoid with liver disease and limit use to 6-week cycles.

Rare

Headache, dizziness, skin sensitivity to sunlight.

Sulbutiamine

Common

Headache, insomnia, irritability, nausea. Tolerance develops with daily use.

Serious

No serious adverse effects documented.

Rare

Skin rash, mood instability, agitation.

Full Profiles